<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="//visiopharm.com.upd.mtra.in/wp-content/plugins/wordpress-seo/css/main-sitemap.xsl"?>
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd http://www.google.com/schemas/sitemap-image/1.1 http://www.google.com/schemas/sitemap-image/1.1/sitemap-image.xsd" xmlns="http://www.sitemaps.org/schemas/sitemap/0.9">
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/qualitopix-an-ai-driven-solution-for-standardizing-tissue-staining-in-pathology/</loc>
		<lastmod>2024-03-15T10:27:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/solutions-for-all-plex-levels/</loc>
		<lastmod>2024-04-02T10:28:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/improving-bladder-cancer-grading-with-ai-enabled-computer-vision-externally-validating-grading-models-and-incorporating-highly-prognostic-nuclear-features/</loc>
		<lastmod>2024-04-02T12:55:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/evaluation-of-cell-lines-in-combination-with-artificial-intelligenceas-quality-tools-to-monitor-her2-ihc-test-reproducibility/</loc>
		<lastmod>2024-04-03T13:26:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/deep-learning-based-fully-automated-analysis-of-whole-slide-images-can-detect-invasive-breast-carcinomaand-count-ki-67-easily-and-precisely/</loc>
		<lastmod>2024-04-03T13:48:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/artificial-intelligence-assisted-assessment-of-her2-ihc-using-semi-and-fully-automated-workflows-rapid-validation-and-implementation-as-a-quality-assurance-and-risk-mitigation-check-point/</loc>
		<lastmod>2024-04-03T13:48:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/masterclass-webinar-series-mapping-the-biological-landscape-turning-multiplex-images-into-knowledge/</loc>
		<lastmod>2024-05-06T11:37:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/masterclass-webinar-series-the-future-of-ihc-opportunities-and-challenges/</loc>
		<lastmod>2024-05-06T11:45:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/masterclass-webinar-series-the-challenges-of-ihc-standardization-clive-taylor/</loc>
		<lastmod>2024-05-06T11:55:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/masterclass-webinar-series-the-challenges-of-ihc-standardization-series-2-with-rasmus-roge/</loc>
		<lastmod>2024-05-06T11:56:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/masterclass-webinar-series-the-challenges-of-ihc-standardization-series-3-with-dirk-vossen/</loc>
		<lastmod>2024-05-06T11:58:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/masterclass-webinar-series-standardizing-ki-67-assays-using-cell-lines/</loc>
		<lastmod>2024-05-06T12:01:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/masterclass-webinar-series-inter-laboratory-her2-variability-and-daily-quality-control/</loc>
		<lastmod>2024-05-06T12:02:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/masterclass-webinar-series-monitoring-immunohistochemical-stain-quality-with-artificial-intelligence/</loc>
		<lastmod>2024-05-06T12:03:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/masterclass-webinar-series-using-visiopharm-to-support-image-analysis-workflow-qc-and-trust-in-data/</loc>
		<lastmod>2024-06-06T08:00:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/digital-image-analysis-and-a-novel-set-of-cell-line-samples-as-aids-in-the-development-of-a-quantitative-external-quality-assessment-programme-for-ki-67/</loc>
		<lastmod>2024-06-06T10:24:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/continuous-ai-supported-surveillance-of-ihc-assay-performance-for-sustainable-staining-quality/</loc>
		<lastmod>2024-06-06T12:26:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/masterclass-webinar-series-the-challenges-of-ihc-standardization-series-5-with-colin-tristram/</loc>
		<lastmod>2024-06-28T08:42:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/uk-neqas-qualitopix-webinar-challenges-of-ihc-standardisation/</loc>
		<lastmod>2024-07-12T08:10:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/masterclass-webinar-series-host-factor-unveiling-pancreatic-cancer-microenvironment-neighborhoods-through-highplex-imaging-and-spatial-profiling/</loc>
		<lastmod>2024-07-18T15:12:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/phenoplex-spatial-biology/</loc>
		<lastmod>2024-08-14T13:00:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/host-factor-a-comprehensive-platform-for-single-cell-highplex-immunofluorescence-staining-digital-imaging-spatial-mapping-and-quantitative-analysis-of-the-tumor-microenvironment/</loc>
		<lastmod>2024-10-15T12:15:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/phenoplex-analysis-of-a-30-plex-assay-multiplex-image/</loc>
		<lastmod>2024-10-15T14:00:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/innovative-imaging-analysis-approaches/</loc>
		<lastmod>2024-10-21T14:24:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/fatty-acid-metabolism-limits-type-i-interferon-responses-in-irradiated-glioblastoma/</loc>
		<lastmod>2024-11-07T16:04:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/long-term-skin-tissue-maintenance-for-the-benefit-of-product-efficiency/</loc>
		<lastmod>2024-12-04T16:12:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/introducing-qualitopix/</loc>
		<lastmod>2024-12-16T14:28:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/phenoplex-interactive-multiview-analysis/</loc>
		<lastmod>2025-01-21T11:54:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/phenoplex-guided-workflow/</loc>
		<lastmod>2025-01-21T12:01:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/phenoplex-workflow/</loc>
		<lastmod>2025-01-21T12:19:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/ai-assisted-metastasis-detection-in-lymph-nodes/</loc>
		<lastmod>2025-01-21T12:29:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/why-and-how-should-digital-pathology-be-implemented-into-clinical-practice/</loc>
		<lastmod>2025-01-30T14:47:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/what-to-consider-when-choosing-an-image-analysis-solution-for-phenotyping/</loc>
		<lastmod>2025-01-30T14:48:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/why-and-how-should-pathologists-keep-up-with-ai/</loc>
		<lastmod>2025-01-30T14:49:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/reimbursement-for-digital-pathology-in-the-clinic-how-does-that-work/</loc>
		<lastmod>2025-01-30T14:50:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/introduction-to-multiplex-for-tissue-image-analysis/</loc>
		<lastmod>2025-01-30T14:51:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/how-to-make-sense-of-multiplex-data-with-phenotyping/</loc>
		<lastmod>2025-01-30T14:52:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/from-digital-microscopy-to-digital-pathology-through-image-analysis-how-far-have-we-come-in-20-years/</loc>
		<lastmod>2025-01-30T14:54:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/why-and-how-is-ai-taking-over-the-tissue-image-analysis-field/</loc>
		<lastmod>2025-01-30T14:54:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/immuno-oncology-basics-and-how-image-analysis-can-help/</loc>
		<lastmod>2025-01-30T14:55:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/how-image-analysis-and-artificial-intelligence-support-digital-pathology-enabled-precision-medicine-today-and-what-to-expect-in-the-future/</loc>
		<lastmod>2025-01-30T14:55:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/cell-lines-are-non-inferior-to-tonsil-as-controls-for-ki-67-assays-when-measured-by-image-analysis/</loc>
		<lastmod>2025-01-30T15:07:18+00:00</lastmod>
		<image:image>
			<image:loc>https://visiopharm.com.upd.mtra.in/wp-content/uploads/Poster-890x880-1.png</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/the-utilization-of-artificial-intelligence-to-produce-clinically-relevant-scores-on-pd-l1-immunostained-non-small-cell-lung-cancer-biopsies/</loc>
		<lastmod>2025-01-30T15:15:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/improved-understanding-of-the-biology-and-pathophysiology-of-the-tme-in-pdac-samples-revealed-using-insituplex-imaging-mass-cytometry-and-phenoplex/</loc>
		<lastmod>2025-01-30T15:20:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/automated-artificial-intelligence-based-analysis-to-support-clinical-assessments-of-ki-67-immunohistochemistry-stained-neuroendocrine-tumors-in-the-routine-workflow/</loc>
		<lastmod>2025-01-30T15:21:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/a-comprehensive-workflow-for-highplex-imaging-tissue-segmentation-and-multiplex-cellular-phenotyping-for-tumor-microenvironment-analysis/</loc>
		<lastmod>2025-01-30T15:30:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/immune-profiling-of-immunotherapy-and-adjuvant-chemotherapy-pretreatment-of-nsclc-tissues-by-codex/</loc>
		<lastmod>2025-01-30T15:31:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/development-of-a-spatial-metabolic-map-of-immunotherapy-sensitive-and-resistant-cutaneous-skin-carcinoma/</loc>
		<lastmod>2025-01-30T15:32:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/imaging-mass-cytometry-enables-identification-of-distinct-tissue-phenotypes-in-highly-autofluorescent-lung-and-colon-cancer-tissues-producing-consistent-data-across-serial-sections/</loc>
		<lastmod>2025-01-30T15:33:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/delineation-of-spatial-tissue-signatures-of-immunotherapy-response-groups-in-non-small-cell-lung-cancer-nsclc/</loc>
		<lastmod>2025-01-30T15:42:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/mapping-the-tumor-microenvironment-with-sequential-immunofluorescence-an-automated-image-analysis-pipeline-and-spatial-metrics/</loc>
		<lastmod>2025-01-30T15:42:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/high-plex-spatial-proteomic-profiling-of-immunotherapy-response-groups-in-head-and-neck-cancer-identifies-tissues-signatures-associated-with-therapy-response/</loc>
		<lastmod>2025-01-30T15:43:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/identification-of-distinct-tissue-phenotypes-in-lung-and-colorectal-cancers-by-imaging-mass-cytometry-is-consistent-across-serial-sections/</loc>
		<lastmod>2025-01-30T15:44:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/an-ai-based-automated-workflow-for-identification-and-scoring-of-invasive-tumor-in-ki-67-stained-breast-cancer-specimens/</loc>
		<lastmod>2025-01-30T15:44:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/spatial-profiling-of-the-tumor-microenvironment-in-head-and-neck-cancer-identifies-immune-checkpoints-and-proteins-involved-in-cell-death-signaling-biomarkers-of-immunotherapy-response/</loc>
		<lastmod>2025-01-30T15:52:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/inter-laboratory-variability-of-her2-low-analysis-using-artificial-intelligence/</loc>
		<lastmod>2025-01-30T15:53:01+00:00</lastmod>
		<image:image>
			<image:loc>https://visiopharm.com.upd.mtra.in/wp-content/uploads/Poster-890x880-1.png</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/improving-pd-l1-quality-control-using-a-dynamic-rangecell-line-and-qualitopix-analysis/</loc>
		<lastmod>2025-01-30T15:53:34+00:00</lastmod>
		<image:image>
			<image:loc>https://visiopharm.com.upd.mtra.in/wp-content/uploads/Poster-890x880-1.png</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/validating-an-ai-based-analytic-tool-for-ihc-staining-qa-precision-studies-of-the-digital-pathology-pipeline/</loc>
		<lastmod>2025-01-30T15:54:12+00:00</lastmod>
		<image:image>
			<image:loc>https://visiopharm.com.upd.mtra.in/wp-content/uploads/Poster-890x880-1.png</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/introducing-phenoplex/</loc>
		<lastmod>2025-01-31T09:26:49+00:00</lastmod>
		<image:image>
			<image:loc>https://visiopharm.com.upd.mtra.in/wp-content/uploads/Jim-190x233-1.png</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/identify-her2-low-populations-utilize-ai-to-monitor-staining-consistency-and-precisely-measure-her2-expression/</loc>
		<lastmod>2025-01-31T09:50:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/advanced-image-analysis-capabilities-to-enhance-drug-discovery/</loc>
		<lastmod>2025-01-31T10:03:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/an-automated-image-analysis-pipeline-for-highplex-sequential-immunofluorescence-images/</loc>
		<lastmod>2025-01-31T10:04:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/phenoplex-workflow-video/</loc>
		<lastmod>2025-01-31T10:27:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/oncotopix-discovery-deep-learning-as-a-standard-analysis-method-for-digital-pathology-images/</loc>
		<lastmod>2025-01-31T12:17:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/impaired-dendritic-cell-homing-in-covid-19/</loc>
		<lastmod>2025-01-31T12:18:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/transforming-pathology-through-ai-based-image-analysis-and-workflow-solution/</loc>
		<lastmod>2025-01-31T12:21:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/multiplex-phenotyping-enabling-tissue-microenvironments-insights/</loc>
		<lastmod>2025-01-31T13:47:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/the-integration-of-visiopharms-ai-apps-and-workflow-at-the-ohio-state-university/</loc>
		<lastmod>2025-01-31T13:53:00+00:00</lastmod>
		<image:image>
			<image:loc>https://visiopharm.com.upd.mtra.in/wp-content/uploads/Webinar-social-1200x627-1.png</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/from-high-background-to-complex-staining-patterns-using-ai-to-extract-what-the-eyes-can-see-but-the-software-typically-cannot-tell-3/</loc>
		<lastmod>2025-01-31T13:53:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/automating-quantitative-nuclear-fluorescence-analysis-in-histological-kidney-and-pancreas-sections-using-convolutional-neural-networks/</loc>
		<lastmod>2025-01-31T13:55:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/phenotyping-cell-populations-in-multiplexed-image-analysis-using-deep-learning/</loc>
		<lastmod>2025-01-31T13:57:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/histopathological-scoring-of-non-alcoholic-fatty-liver-disease-using-deep-learning/</loc>
		<lastmod>2025-01-31T13:58:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/advanced-phenotyping-of-the-tumor-immune-microenvironment/</loc>
		<lastmod>2025-01-31T14:26:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/strategy-for-visualizing-quantifying-and-mapping-immune-cells-in-the-tumor-microenvironment/</loc>
		<lastmod>2025-01-31T14:27:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/extraction-of-histomorphological-data-using-artificial-intelligence/</loc>
		<lastmod>2025-01-31T14:28:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/development-and-analytical-validation-of-prognostic-biomarkers-for-metastasis/</loc>
		<lastmod>2025-01-31T14:29:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/the-inhibitory-role-of-specific-macrophages-in-rcc/</loc>
		<lastmod>2025-01-31T14:30:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/overcoming-5-obstacles-to-scaling-digital-pathology-in-life-sciences-research/</loc>
		<lastmod>2025-01-31T14:36:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/improving-diagnostic-workflows-with-ai-lymph-node-metastasis-detection-in-breast-and-colorectal-cancer/</loc>
		<lastmod>2025-01-31T15:05:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/investigate-the-tumor-microenvironment-with-high-plex-imaging/</loc>
		<lastmod>2025-01-31T15:06:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/investigating-tumor-blood-vessels-via-digital-pathology-spotlight-on-breast-cancer-and-glioblastoma/</loc>
		<lastmod>2025-01-31T15:07:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/fluorescence-analysis-using-deep-learning-to-stratify-mitotic-events/</loc>
		<lastmod>2025-01-31T15:08:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/oncotopix-insight-entreprise-workflow-video-ruo-research-use-only/</loc>
		<lastmod>2025-03-13T12:52:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/oncotopix-insight-entreprise-workflow-video-eu-uk-only/</loc>
		<lastmod>2025-03-13T12:53:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/pd-l1-one-pager/</loc>
		<lastmod>2025-03-24T16:11:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/her2-low-one-pager/</loc>
		<lastmod>2025-03-26T12:17:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/application-of-digital-image-analysis-for-the-assessment-of-her2-low-in-breast-cancer/</loc>
		<lastmod>2025-03-26T15:01:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/inter-rater-agreement-of-her2-and-her2-low-scores-in-breast-cancer-between-the-visiopharm-digital-image-analysis-her2-application-and-a-group-of-expert-pathologists/</loc>
		<lastmod>2025-03-26T15:07:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/qualitopix-one-pager/</loc>
		<lastmod>2025-03-31T13:00:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/enhancing-rna-ish-spot-detection-with-dual-channel-staining-and-ai-analysis/</loc>
		<lastmod>2025-04-15T12:40:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/enhancing-cellular-specificity-of-rna-ish-spot-detection-using-dual-channel-staining-andai-based-analysis-methods/</loc>
		<lastmod>2025-04-15T12:41:37+00:00</lastmod>
		<image:image>
			<image:loc>https://visiopharm.com.upd.mtra.in/wp-content/uploads/Poster-890x880-1.png</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/dissecting-the-myeloid-compartment-of-the-tumor-microenvironment-with-signalstartm-multipleximmunohistochemistry-and-phenoplex-image-analysis/</loc>
		<lastmod>2025-04-15T12:42:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/a-deep-learning-approach-to-guide-acquisition-region-selection-for-imaging-mass-cytometry/</loc>
		<lastmod>2025-04-15T12:43:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/masterclass-webinar-series-multiplex-multi-omics-the-future-of-spatial-biology/</loc>
		<lastmod>2025-04-15T12:43:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/multiomic-spatial-profiling-of-the-tumor-immune-microenvironment/</loc>
		<lastmod>2025-04-15T12:45:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/phenoplex-spatial-analysis-of-whole-slide-colon-adenocarcinoma-imaged-with-orion-13-plex-one-round-staining-and-imaging/</loc>
		<lastmod>2025-05-01T06:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/spatial-analysis-of-the-dlbcl-tumor-microenvironment-via-the-novel-signalstarmultiplex-immunohistochemistry-assay/</loc>
		<lastmod>2025-05-01T06:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/development-of-a-multiomic-workflow-using-oncore-pro-x-to-stain-tissues-for-high-performance-dual-channel-validation-of-rna-expression-with-downstream-quantitation-using-ai-based-image-analys/</loc>
		<lastmod>2025-05-01T06:00:00+00:00</lastmod>
		<image:image>
			<image:loc>https://visiopharm.com.upd.mtra.in/wp-content/uploads/Poster-890x880-1.png</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/relapse-prediction-of-stage-iii-mss-colon-cancer-by-certain-cell-subtype-distribution-characteristics-in-tumor-and-tumor-invasive-margin/</loc>
		<lastmod>2025-05-01T06:00:00+00:00</lastmod>
		<image:image>
			<image:loc>https://visiopharm.com.upd.mtra.in/wp-content/uploads/Poster-890x880-1.png</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/automating-a-spatial-profiling-workflow-to-explore-the-effects-of-hypoxia-in-the-tumor-microenvironment-in-head-and-neck-cancer/</loc>
		<lastmod>2025-05-01T06:00:00+00:00</lastmod>
		<image:image>
			<image:loc>https://visiopharm.com.upd.mtra.in/wp-content/uploads/Poster-890x880-1.png</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/discovery-brochure/</loc>
		<lastmod>2025-05-06T12:59:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/liver-research-one-pager/</loc>
		<lastmod>2025-05-07T10:50:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/straticyte-by-proteocyteai/</loc>
		<lastmod>2025-05-07T10:57:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/histological-characterizationof-a-pkd1-knockout-mouse-strain-kidney-research-one-pager/</loc>
		<lastmod>2025-05-07T10:58:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/improving-bladder-cancer-grading-one-pager/</loc>
		<lastmod>2025-05-07T10:58:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/animal-free-skin-research-model-accurately-quantified-one-pager/</loc>
		<lastmod>2025-05-07T10:59:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/harnessing-technology-a-comparative-study-of-ai-versus-manual-scoring-in-her2-ultra-low-breast-cancer/</loc>
		<lastmod>2025-05-14T08:53:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/deepdx-prostate-ruo-research-use-only/</loc>
		<lastmod>2025-05-14T08:55:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/ai-assisted-detection-of-sentinel-lymph-node-metastasis-in-penilesquamous-cell-carcinoma-reducing-immunostaining-dependence/</loc>
		<lastmod>2025-05-14T08:56:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/insight-one-pager-eu-uk-only/</loc>
		<lastmod>2025-05-22T11:42:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/insight-one-pager-ruo-research-use-only/</loc>
		<lastmod>2025-05-22T11:43:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/masterclass-webinar-series-how-to-achieve-consistently-accurate-ihc-test-results/</loc>
		<lastmod>2025-06-17T12:29:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/masterclass-webinar-series-new-views-in-spatial-biology-multiplexed-imaging-for-rapid-whole-slide-analysis/</loc>
		<lastmod>2025-06-17T13:49:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/decoding-the-liver-microenvironment-with-phenoplex/</loc>
		<lastmod>2025-06-17T14:13:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/discovery-video/</loc>
		<lastmod>2025-10-27T14:16:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/ai-guided-spatial-profiling-of-tertiary-lymphoid-structures-in-human-lung-cancer-byimaging-mass-cytometry/</loc>
		<lastmod>2025-11-06T14:12:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/her2-app-breast-cancer-based-algorithm-for-precise-scoring-of-her2-null-ultra-low-and-low-expression-as-an-alternative-to-asco-cap-visual-scoring-an-analysis-of-422-cases/</loc>
		<lastmod>2025-11-25T13:31:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/spatial-immunometabolic-profiling-of-non-small-cell-lung-cancer-reveals-distinct-immune-exclusion-patterns-and-functional-niches/</loc>
		<lastmod>2025-11-25T13:33:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/how-multispectral-imaging-enables-analysis-of-macrophages-in-chronic-liver-disease/</loc>
		<lastmod>2025-12-09T10:57:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/masterclass-webinar-series-a-novel-global-phenotyping-method-using-artificial-intelligence-to-overcome-the-cell-segmentation-bottleneck/</loc>
		<lastmod>2025-12-15T12:52:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://visiopharm.com.upd.mtra.in/resources/chromogenic-multiplexthe-future-of-clinical-biomarkers/</loc>
		<lastmod>2025-12-17T14:20:40+00:00</lastmod>
	</url>
</urlset>
<!-- XML Sitemap generated by Yoast SEO -->